Power and Promise of Next-Generation Sequencing in Liquid Biopsies and Cancer Control
Traditional methods of cancer treatment are usually based on the morphological and histological diagnosis of tumors, and they are not optimized according to the specific situation. Precision medicine adjusts the existing treatment regimen based on the patient’s genomic information to make it most su...
Main Authors: | Ting-Miao Wu M.M, Ji-Bin Liu MD, Yu Liu PhM, Yi Shi PhM, Wen Li PhD, Gao-Ren Wang MD, Yu-Shui Ma PhD, Da Fu PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-08-01
|
Series: | Cancer Control |
Online Access: | https://doi.org/10.1177/1073274820934805 |
Similar Items
-
A Case of Lung Adenocarcinoma Harboring a Rare LOC285000-ALK-NCK2 Gene Fusion Identified by Next-Generation Sequencing With Long-Term Response to Crizotinib
by: Min Zhang, MBBS, et al.
Published: (2021-02-01) -
Techniques of intracranial aneurysm wall biopsy
by: Sajjad Muhammad, MD, PhD, et al.
Published: (2019-09-01) -
Early repolarization syndrome caused by de novo duplication of KCND3 detected by next-generation sequencing
by: Samuel Chauveau, MD, et al.
Published: (2017-12-01) -
An atypical case of Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)-associated renal cell carcinoma identified by next-generation sequencing
by: Daniel R. Matson, M.D., Ph.D., et al.
Published: (2018-03-01) -
Bleeding Risk Related to Upper Gastrointestinal Endoscopic Biopsy in Patients Receiving Antithrombotic Therapy: A Multicenter Prospective Observational Study
by: Takafumi Yuki, MD, PhD, et al.
Published: (2017-01-01)